0.8713
price down icon2.99%   -0.0269
 
loading

Scisparc Ltd (SPRC) 最新ニュース

SciSparc Ltd. Enhances Loan Agreement with AutoMax - TipRanks.com - TipRanks

pulisher
TipRanks

SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe - Quantisnow

pulisher
Quantisnow

Ratio Review: Analyzing SciSparc Ltd (SPRC)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex

pulisher
The Dwinnex

SciSparc Ltd. Secures European Patent Boost - TipRanks.com - TipRanks

pulisher
TipRanks

SciSparc secures European patent for antimicrobial method - Investing.com India

pulisher
Investing.com India

SciSparc Secures Strategic Advantage with Grant of European Patent - GlobeNewswire

pulisher
GlobeNewswire

SPRC’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

pulisher
The InvestChronicle

SciSparc secures European patent for antimicrobial method By Investing.com - Investing.com

pulisher
Investing.com

Understanding SPRC's book value per share for better investment insights – US Post News - US Post News

pulisher
US Post News

SciSparc Secures Strategic Advantage with Grant of European Patent - GlobeNewswire

pulisher
GlobeNewswire

SciSparc Secures Strategic Advantage with Grant of European Patent

pulisher
GlobeNewswire Inc.

SciSparc secures European patent for antimicrobial method By Investing.com - Investing.com

pulisher
Investing.com

SciSparc stock rallies 67% on positive results for Alzheimer's drug - MSN

pulisher
MSN

SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification - MSN

pulisher
MSN

SPRC Stock Price and Chart — NASDAQ:SPRC - TradingView

pulisher
TradingView

SciSparc stock rallies 67% on positive results for Alzheimer's drug - MSN

pulisher
MSN

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

SciSparc Announces Strategic Merger with Automax Motors - TipRanks.com - TipRanks

pulisher
TipRanks

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

SciSparc to Acquire AutoMax

pulisher
GlobeNewswire Inc.

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification - SciSparc (NASDAQ:SPRC) - Benzinga

pulisher
Benzinga

SciSparc Advances Depression Treatment with New Patent - TipRanks.com - TipRanks

pulisher
TipRanks

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

pulisher
GlobeNewswire Inc.

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating ... - GlobeNewswire

pulisher
GlobeNewswire

SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research - GlobeNewswire

pulisher
GlobeNewswire

SciSparc Granted Another Patent, Strengthening its Core Technology in Canada

pulisher
GlobeNewswire Inc.

SciSparc Granted Another Patent, Strengthening its Core Technology in Canada - GlobeNewswire

pulisher
GlobeNewswire

SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

pulisher
GlobeNewswire Inc.

SciSparc doses first patient with CBD-containing drug in autism trial - Clinical Trials Arena

pulisher
Clinical Trials Arena

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure

pulisher
GlobeNewswire Inc.

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure - GlobeNewswire

pulisher
GlobeNewswire

SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder

pulisher
GlobeNewswire Inc.

SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder - GlobeNewswire

pulisher
GlobeNewswire

SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe

pulisher
GlobeNewswire Inc.

SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe - GlobeNewswire

pulisher
GlobeNewswire

SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology

pulisher
GlobeNewswire Inc.

SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology - GlobeNewswire

pulisher
GlobeNewswire

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

pulisher
GlobeNewswire Inc.

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing - Yahoo Finance

pulisher
Yahoo Finance

SciSparc says Clearmind files three new international patent applications - TipRanks.com - TipRanks

pulisher
TipRanks

SciSparc says Clearmind files three new international patent applications - TipRanks.com - TipRanks

pulisher
TipRanks

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds

pulisher
GlobeNewswire Inc.

Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based ... - Yahoo Finance

pulisher
Yahoo Finance

SciSparc begins trial of therapy for autism spectrum disorder - Clinical Trials Arena

pulisher
Clinical Trials Arena

SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

pulisher
GlobeNewswire Inc.

Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Crude Oil Rises Over 1%; DuPont Shares Plunge

pulisher
Benzinga
$146.84
price down icon 2.64%
$85.33
price up icon 0.48%
$25.67
price down icon 0.39%
$84.20
price down icon 2.90%
$447.85
price down icon 0.91%
$245.08
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):